CordenPharma Increases U.S. Peptide Manufacturing Capacity

URLhttps://www.contractpharma.com/contents/view_break
SourceContract Pharma
Date Published07/08/2020
Mentions specific company case(s) of reshoring, kept from offshoring, or transplantYes

Additional Reshoring Information:

Company/Division name CordenPharma
Type of work Manufacturing
Reshoring category:Foreign Direct Investment
Year reshoring announced:2020
Domestically, the work will be done:In-house
Country(ies) from which reshored:Germany
City reshored to:Boulder
State(s) reshored to:CO
If relevant, work nearshored to:-
Industry(ies):Chemicals
Product(s) reshoredpeptide APIs
Find Reshoring Articles